litlas
ログインアカウント作成

Philip J. Clements

1974–2022 年に発表

別表記
PHILIP J. CLEMENTS
86
論文数
20,261
被引用数
78
h 指数
86
i10 指数

被引用数

Philip J. Clements の年別被引用数1974 年: 被引用 4 件1975 年: 被引用 9 件1976 年: 被引用 4 件1977 年: 被引用 1 件1978 年: 被引用 8 件1979 年: 被引用 9 件1980 年: 被引用 2 件1981 年: 被引用 13 件1982 年: 被引用 14 件1983 年: 被引用 5 件1984 年: 被引用 5 件1985 年: 被引用 13 件1986 年: 被引用 11 件1987 年: 被引用 7 件1988 年: 被引用 6 件1989 年: 被引用 10 件1990 年: 被引用 10 件1991 年: 被引用 14 件1992 年: 被引用 12 件1993 年: 被引用 10 件1994 年: 被引用 18 件1995 年: 被引用 10 件1996 年: 被引用 32 件1997 年: 被引用 24 件1998 年: 被引用 21 件1999 年: 被引用 21 件2000 年: 被引用 23 件2001 年: 被引用 31 件2002 年: 被引用 43 件2003 年: 被引用 61 件2004 年: 被引用 44 件2005 年: 被引用 45 件2006 年: 被引用 74 件2007 年: 被引用 101 件2008 年: 被引用 75 件2009 年: 被引用 113 件2010 年: 被引用 93 件2011 年: 被引用 113 件2012 年: 被引用 93 件2013 年: 被引用 71 件2014 年: 被引用 105 件2015 年: 被引用 132 件2016 年: 被引用 171 件2017 年: 被引用 138 件2018 年: 被引用 160 件2019 年: 被引用 750 件2020 年: 被引用 706 件2021 年: 被引用 618 件2022 年: 被引用 460 件2023 年: 被引用 271 件2024 年: 被引用 484 件2025 年: 被引用 185 件2026 年: 被引用 4 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,313 件、この内訳の 21.7%イタリア: 引用元論文 571 件、この内訳の 9.4%イギリス: 引用元論文 543 件、この内訳の 8.9%フランス: 引用元論文 405 件、この内訳の 6.7%ドイツ: 引用元論文 355 件、この内訳の 5.8%カナダ: 引用元論文 272 件、この内訳の 4.5%スイス: 引用元論文 252 件、この内訳の 4.1%日本: 引用元論文 217 件、この内訳の 3.6%中国: 引用元論文 205 件、この内訳の 3.4%オランダ: 引用元論文 204 件、この内訳の 3.4%オーストラリア: 引用元論文 149 件、この内訳の 2.5%スペイン: 引用元論文 144 件、この内訳の 2.4%
0%21.7%その他 23.6%

機関

分野

  • Medicine92.8%
  • Biochemistry, Genetics and Molecular Biology2.7%
  • Immunology and Microbiology2.3%
  • Neuroscience0.5%
  • Engineering0.3%
  • Economics, Econometrics and Finance0.2%
  • その他1.2%

トピック

  • Systemic Sclerosis and Related Diseases23.2%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis11.4%
  • Inflammatory Myopathies and Dermatomyositis8%
  • Pulmonary Hypertension Research and Treatments3.5%
  • Multiple Sclerosis Research Studies3.3%
  • Dermatologic Treatments and Research2.7%
  • その他47.9%

共著者

全論文

検索で開く
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    著者: F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R. Johnson, Murray Baron, Alan Tyndall, Marco Matucci‐Cerinic, Raymond P. Naden, Thomas A. Medsger, Patrícia Carreira, Gabriela Riemekasten, Philip J. Clements, Christopher P. Denton, Oliver Distler, Yannick Allanore, Daniel E. Furst, Armando Gabrielli, Maureen D. Mayes, Jacob M. van Laar, James R. Seibold, László Czirják, Virginia Steen, Murat İnanç, Otylia Kowal‐Bielecka, Ulf Müller‐Ladner, Gabriele Valentini, Douglas J. Veale, Madelon C Vonk, Ulrich A. Walker, Lorinda Chung, David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 被引用: 3,406

  2. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    著者: Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Dinesh Khanna, Eric C. Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R. Volkmann, Suzanne Kafaja, Richard M. Silver, Virginia Steen, Charlie Strange, Robert A. Wise, Fredrick M. Wigley, Maureen D. Mayes, D. Jason Riley, Sabiha Hussain, Shervin Assassi, Vivien Hsu, Bela Patel, Kristine Phillips, Fernando J. Martínez, Jeffrey A. Golden, M. Kari Connolly, John Varga, Jane Dematte, Monique Hinchcliff, Aryeh Fischer, Jeffrey J. Swigris, Richard T. Meehan, Arthur C. Theodore, Robert W. Simms, Suncica Volkov, Dean E. Schraufnagel, Mary Beth Scholand, Tracy Frech, Jerry A. Molitor, Kristin B. Highland, Charles A. Read, Marvin J. Fritzler, Grace Hyun J. Kim, Chi‐Hong Tseng, Robert M. Elashoff - The Lancet Respiratory Medicine 2016 被引用: 1,062

  3. Update of EULAR recommendations for the treatment of systemic sclerosis

    著者: Otylia Kowal‐Bielecka, Jaap Fransen, Jérôme Avouac, Mike Oliver Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip J. Clements, Maurizio Cutolo, László Czirják, Nemanja Damjanov, Francesco Del Galdo, Christopher P. Denton, Jörg H. W. Distler, Ivan Foeldvari, Kim Figelstone, M. Frerix, Daniel E Furst, Serena Guiducci, Nicolas Hunzelmann, Dinesh Khanna, Marco Matucci‐Cerinic, Ariane L. Herrick, F.H.J. van den Hoogen, Jacob M. van Laar, Gabriela Riemekasten, Richard M. Silver, Vanessa Smith, Alberto Sulli, Ingo H. Tarner, Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana ほか 35 名 - Annals of the Rheumatic Diseases 2016 被引用: 1,116

  4. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

    著者: Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Jonathan Goldin, Michael D. Roth, Daniel E. Furst, Edgar Arriola, Richard M. Silver, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fredrick M. Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky - New England Journal of Medicine 2006 被引用: 1,667

  5. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    著者: Dinesh Khanna, Daniel E. Furst, Philip J. Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler, Ivan Foeldvari, Masataka Kuwana, Marco Matucci‐Cerinic, Maureen D. Mayes, Thomas A. Medsger, Peter A. Merkel, Janet Pope, James R. Seibold, Virginia Steen, Wendy Stevens, Christopher P. Denton - Journal of Scleroderma and Related Disorders 2017 被引用: 521

  6. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Myung‐Shin Sim, Ning Li, Ellen Goldmuntz, Lynette Keyes-Elstein, Ashley Pinckney, Daniel E. Furst, Philip J. Clements, Dinesh Khanna, Virginia Steen, Dean E. Schraufnagel, Shiva Arami, Vivien Hsu, Michael D. Roth, Robert M. Elashoff, Keith M. Sullivan - Annals of the Rheumatic Diseases 2018 被引用: 198

  7. Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

    著者: Dinesh Khanna, Ron D. Hays, Paul Maranian, James R. Seibold, Ann Impens, Maureen D. Mayes, Philip J. Clements, Terri Getzug, Nihal Fathi, Amber Bechtel, Daniel E. Furst - Arthritis Care & Research 2009 被引用: 247

  8. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Ning Li, Michael D. Roth, Dinesh Khanna, Anna‐Maria Hoffmann‐Vold, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Robert M. Elashoff - Arthritis & Rheumatology 2017 被引用: 159

  9. Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

    著者: Suzanne Kafaja, Philip J. Clements, Holly Wilhalme, Chi‐Hong Tseng, Daniel E. Furst, Grace Hyun J. Kim, Jonathan Goldin, Elizabeth R. Volkmann, Michael D. Roth, Donald P. Tashkin, Dinesh Khanna - American Journal of Respiratory and Critical Care Medicine 2017 被引用: 126

  10. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II

    著者: Jonathan Goldin, Grace Hyun J. Kim, Chi‐Hong Tseng, Elizabeth R. Volkmann, Daniel E. Fürst, Philip J. Clements, Matthew A. Brown, Michael D. Roth, Dinesh Khanna, Donald P. Tashkin - Annals of the American Thoracic Society 2018 被引用: 112

  11. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

    著者: Otylia Kowal‐Bielecka, Robert Landewé, Jérôme Avouac, Sylwia Chwieśko, Irene Miniati, László Czirják, Philip J. Clements, Chris Denton, Dominique Farge, Kim Fligelstone, I Földvari, D E Furst, Ulf Müller‐Ladner, James R. Seibold, Richard M. Silver, Kazuhiko Takehara, B Garay Toth, Alan Tyndall, Gabriele Valentini, F.H.J. van den Hoogen, F Wigley, Francesco Zulian, Marco Matucci‐Cerinic - Annals of the Rheumatic Diseases 2009 被引用: 617

  12. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

    著者: Dinesh Khanna, Veronica J. Berrocal, Edward H. Giannini, James R. Seibold, Peter A. Merkel, Maureen D. Mayes, Murray Baron, Philip J. Clements, Virginia Steen, Shervin Assassi, Elena Schiopu, Kristine Phillips, Robert W. Simms, Yannick Allanore, Christopher P. Denton, Oliver Distler, Sindhu R. Johnson, Marco Matucci‐Cerinic, Janet Pope, Susanna Proudman, Jeffrey Siegel, Weng Kee Wong, Athol U. Wells, Daniel E. Furst - Arthritis & Rheumatology 2016 被引用: 156

  13. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Michael D. Roth, Philip J. Clements, Dinesh Khanna, Daniel E. Furst, Maureen D. Mayes, Julio Charles, Chi‐Hong Tseng, Robert M. Elashoff, Shervin Assassi - Arthritis Research & Therapy 2016 被引用: 86

  14. Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium

    著者: Elizabeth R. Volkmann, Yu‐Ling Chang, Nashla Barroso, Daniel E. Fürst, Philip J. Clements, Alan Gorn, Bennett E. Roth, Jeffrey L. Conklin, Terri Getzug, James Borneman, Dermot McGovern, Maomeng Tong, Jonathan P. Jacobs, Jonathan Braun - Arthritis & Rheumatology 2016 被引用: 122

  15. Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

    著者: Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, Michael D. Roth, Daniel E. Furst, Richard M. Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B. Bolster, James R. Seibold, D. Riley, Vivien Hsu, John Varga, Dean E. Schraufnagel, Arthur C. Theodore, Robert W. Simms, Robert A. Wise, Fred Wigley, Barbara White, Virginia Steen, Charles A. Read, Maureen D. Mayes, Ed Parsley, Kamal K. Mubarak, M. Kari Connolly, Jeffrey A. Golden, Mitchell A. Olman, Barri J. Fessler, Naomi F. Rothfield, Mark L. Metersky, Dinesh Khanna, Ning Li, Gang Li - American Journal of Respiratory and Critical Care Medicine 2007 被引用: 464

  16. High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

    著者: Jonathan Goldin, David A. Lynch, Diane C. Strollo, Robert D. Suh, Dean E. Schraufnagel, Philip J. Clements, Robert M. Elashoff, Daniel E. Furst, Sarinnapha M. Vasunilashorn, Michael F. McNitt‐Gray, Mathew S. Brown, Michael D. Roth, Donald P. Tashkin - CHEST Journal 2008 被引用: 244

  17. Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

    著者: Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Hyun J. Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Dinesh Khanna - ACR Open Rheumatology 2020 被引用: 55

  18. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients.

    著者: H G Kim, Donald P. Tashkin, Philip J. Clements, Genliang Li, Matt Brown, Robert M. Elashoff, David W. Gjertson, Fereidoun Abtin, David A. Lynch, Diane C. Strollo, Jonathan Goldin - 2010 被引用: 132

  19. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts

    著者: Elizabeth R. Volkmann, Anna‐Maria Hoffmann‐Vold, Yu‐Ling Chang, Jonathan P. Jacobs, Kirsten Tillisch, Emeran A. Mayer, Philip J. Clements, Johannes R. Hov, Martin Kummen, Øyvind Midtvedt, Venu Lagishetty, Lin Chang, Jennifer S. Labus, Øyvind Molberg, Jonathan Braun - BMJ Open Gastroenterology 2017 被引用: 105

  20. Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo‐Controlled Trials

    著者: Rajaie Namas, Donald P. Tashkin, Daniel E. Furst, Holly Wilhalme, Chi‐Hong Tseng, Michael D. Roth, Suzanne Kafaja, Elizabeth R. Volkmann, Philip J. Clements, Dinesh Khanna - Arthritis Care & Research 2017 被引用: 81

  21. Predictive Significance of Serum Interferon‐Inducible Protein Score for Response to Treatment in Systemic Sclerosis–Related Interstitial Lung Disease

    著者: Shervin Assassi, Ning Li, Elizabeth R. Volkmann, Maureen D. Mayes, Dennis Rünger, Binwu Ying, Michael D. Roth, Monique Hinchcliff, Dinesh Khanna, Tracy Frech, Philip J. Clements, Daniel E. Fürst, Jonathan Goldin, Elana J. Bernstein, Flavia V. Castelino, Robyn T. Domsic, Jessica Gordon, Faye N. Hant, Ami A. Shah, Victoria K. Shanmugam, Virginia Steen, Robert M. Elashoff, Donald P. Tashkin - Arthritis & Rheumatology 2020 被引用: 41

  22. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

    著者: Philip J. Clements, Peter A. Lachenbruch, Jill Siebold, Barbara White, Saul J. Weiner, Richard W. Martin, Arthur Weinstein, Michael Weisman, Maureen D. Mayes, David H. Collier - 1995 被引用: 877

  23. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.

    著者: Daniel E. Fürst, Philip J. Clements, Virginia Steen, Thomas A. Medsger, Alfonse T. Masi, William D’Angelo, Peter A. Lachenbruch, Rafael G. Grau, James R. Seibold - 1998 被引用: 278

  24. Scleroderma renal crisis and renal involvement in systemic sclerosis

    著者: Thasia Woodworth, Yossra A. Suliman, Wendi Li, Daniel E. Furst, Philip J. Clements - Nature Reviews Nephrology 2016 被引用: 165